Real-world effectiveness of eptinezumab in chronic migraine—increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fog

Abstract Background The REVIEW study evaluated the real-world experiences of individuals treated with eptinezumab for chronic migraine (CM) in the outpatient setting. This post hoc analysis explored eptinezumab effectiveness in three participant subgroups: those who had self-reported psychiatric com...

Full description

Bibliographic Details

Main Authors:	Charles Argoff, Fawad A. Khan, Steven P. Herzog, Ryan M. Smith, Seema Soni-Brahmbhatt, Divya Asher, Susanne F. Awad, S. Wald Grossman, Foram Patel, Dawn C. Buse
Format:	Artigo
Language:	Inglês
Published:	BMC 2025-11-01
Series:	The Journal of Headache and Pain
Subjects:	Chronic migraine Real-world Eptinezumab Prior preventive treatment failures Brain fog Cognition
Online Access:	https://doi.org/10.1186/s10194-025-02165-2
Tags:	Add Tag No Tags, Be the first to tag this record!